We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gcp Asset Backed Income Fund Limited | LSE:GABI | London | Ordinary Share | JE00BYXX8B08 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.60 | 0.88% | 68.60 | 68.60 | 69.00 | 68.80 | 68.00 | 68.80 | 343,878 | 16:23:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 15.18M | 7.69M | 0.0181 | 37.90 | 291.98M |
TIDMGABI
RNS Number : 6641O
GCP Asset Backed Income Fund Ltd
22 August 2017
GCP Asset Backed Income Fund Limited
("GCP Asset Backed" or the "Company")
LEI 213800FBBZCQMP73A815
Total Voting Rights & Additional Listing
22 August 2017
GCP Asset Backed, which invests in asset backed loans, has made an application for 56,315 ordinary shares of no par value in the Company ("New Shares") to be admitted on the Premium Listing Segment of the Official List of the UK Listing Authority and for trading on the London Stock Exchange's Main Market for listed securities. It is expected that these New Shares will be admitted to trading on 4 September 2017.
The application is being made pursuant to the scrip dividend alternative in lieu of cash for the interim dividend for the period from 1 April 2017 to 30 June 2017. Elections for a scrip dividend were received in respect of 1.65% of the ordinary shares in issue as at the record date of 4 August 2017. When issued, these New Shares will rank pari passu with the existing ordinary shares.
Following admission of the New Shares, the Company's issued share capital will consist of 242,845,987 ordinary shares of no par value. With effect from 4 September 2017, the total number of issued shares with voting rights will be 242,845,987.
The above figure of 242,845,987 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in, GCP Asset Backed under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
A copy of the Scrip Dividend Circular has been submitted to the National Storage Mechanism and is available for inspections at: www.hemscott.com/nsm.do and on the Company's website at www.gcpuk.com . The Scrip Dividend Circular can also be obtained from the Company Secretary.
For further information please contact:
Gravis Capital Management Limited + 44 (0) 20 3405 8500 David Conlon david.conlon@gcpuk.com Philip Kent philip.kent@gcpuk.com Dion Di Miceli dion.dimiceli@gcpuk.com Cenkos Securities plc +44 (0)20 7397 8900 Tom Scrivens tscrivens@cenkos.com Oliver Packard opackard@cenkos.com Sapna Shah sshah@cenkos.com Buchanan +44 (0)20 7466 5000 Charles Ryland charlesr@buchanan.uk.com Vicky Hayns victoriah@buchanan.uk.com
Notes to Editors
The Company is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.
The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPTMLTMBITMPR
(END) Dow Jones Newswires
August 22, 2017 05:50 ET (09:50 GMT)
1 Year Gcp Asset Backed Income Chart |
1 Month Gcp Asset Backed Income Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions